Enter your email Address

About
Technology
- EYS606
Pipeline
News
Investors
Contact

Gene Therapy for Ophthalmic Disorders Digital Event

August 5, 2020 - August 6, 2020

This event has passed.

Google Calendar
iCalendar
Outlook 365
Outlook Live

Details

Start:: August 5, 2020
End:: August 6, 2020

Recent Posts

Nonviral Platforms Streamline Gene Therapy Delivery
Eyevensys Announces Positive Preclinical Data Demonstrating Superiority of EYS809 over Aflibercept for Wet Age-Related Macular Degeneration (AMD) at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
ARVO 2023: Eyevensys announces positive preclinical data demonstrating efficacy of EYS809 over aflibercept for wet AMD
Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference
Eyevensys to present at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

American Academy of Ophthalmology – San Francisco, California

Ophthalmology Futures Retina & European Virtual Forums

About Us
Meet the Team
Technology
Pipeline

Contact Us
Scientific Publications
Press Releases
Events

Cookie Policy
Privacy Policy

© 2023 Eyevensys. All rights reserved.

About
Technology
- EYS606
Pipeline
News
Investors
Contact

Start Typing